摘要
目的研究在不稳定型心绞痛患者中采取芪参益气滴丸和尼可地尔联合治疗的临床效果。方法该文实验参考不同治疗方案将2016年11月—2017年11月期间收治的66例不稳定型心绞痛患者随机分为实验组以及参照组,每组33例,参照组患者开展单稍酸异山梨醋片治疗,实验组患者开展芪参益气滴丸和尼可地尔联合治疗,对比分析实验组和参照组患者临床治疗有效率、不良反应发生率、心电图异常发生率。结果实验组不稳定型心绞痛患者临床治疗有效率96.97%、不良反应发生率6.06%、ST段升高发生率3.03%、T波倒置发生率0.00%对比参照组患者临床治疗有效率78.78%、不良反应发生率24.24%、ST段升高发生率24.24%、T波倒置发生率15.15%,差异有统计学意义(P<0.05)。结论将芪参益气滴丸和尼可地尔联合治疗应用在不稳定型心绞痛患者中具有显著疗效,可降低不良反应,提升治疗效果。
Objective To study the clinical effect of atorvastatin calcium combined with nicorandil in unstable angina pectoris patients. Methods 66 patients with unstable angina pectoris treated from November 2016 to November 2017 were randomly divided into experimental group and reference group. A group of 33 patients were treated with monosorbide isosorbide vinegar, and the experimental group was treated with atorvastatin calcium and nicorandil.Treatment, comparative analysis of the experimental group and the reference group patients clinical treatment efficiency,incidence of adverse reactions, abnormal ECG incidence. Results The effective rate of clinical treatment in the patients with unstable angina was 96.97%, the incidence of adverse reaction was 6.06%, the incidence of ST segment elevation was 3.03%, and the incidence of T wave inversion was 0%. The effective rate of clinical treatment was 78.78%, the incidence of adverse reaction was 24.24%, the incidence of ST segment elevation was 24.24%, the incidence of T wave inversion was 15.15%, the difference was statistically significant(P <0.05). Conclusion The combined treatment of atorvastatin calcium and nicorandil has a significant effect in the patients with unstable angina pectoris, which can reduce the adverse reaction and improve the therapeutic effect.
出处
《双足与保健》
2018年第15期17-18,共2页
Biped and Health